1 Day Online Training Course on Effective Defence of EPO (European Patent Office) Patent Applications
27 févr. 2024 12h14 HE
|
Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Effective Defence of EPO (European Patent Office) Patent Applications Training Course" has been added to ResearchAndMarkets.com's offering. Clarity...
TransCode Therapeutics Reports Publication of United States Patent Application Covering TransCode’s RIG-I Agonist Immunotherapeutic
20 févr. 2024 08h00 HE
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Reports Publication of United States Patent Application Covering TransCode’s RIG-I Agonist Immunotherapeutic
Advanced Drafting Techniques for Successful EPO (European Patent Office) Patent Applications: 1-Day Online Training Course (May 10th, 2024)
31 janv. 2024 05h55 HE
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Advanced Drafting Techniques for Successful EPO (European Patent Office) Patent Applications Training Course" conference has been added to ...
BioRestorative Therapies Receives a Notice of Allowance by the United States Patent and Trademark Office for a Patent Application Related to its Obesity Program
12 déc. 2023 09h15 HE
|
BioRestorative Therapies, Inc
--Notice of allowance will be the fourth U.S. patent granted under Company’s ThermoStem® program targeting obesity and metabolic disorders, including type 2 diabetes-- MELVILLE, N.Y., Dec. 12, 2023 ...
Navigate Added Subject Matter and Disclosure Challenges: Advanced Drafting Techniques for Successful EPO (European Patent Office) Patent Applications Training Course (London, UK - November 10, 2023)
16 août 2023 08h58 HE
|
Research and Markets
Dublin, Aug. 16, 2023 (GLOBE NEWSWIRE) -- The "Advanced Drafting Techniques for Successful EPO (European Patent Office) Patent Applications Training Course" conference has been added to ...
Effective Defence of EPO (European Patent Office) Patent Applications Training Course (London, United Kingdom - November 9, 2023)
18 avr. 2023 13h03 HE
|
Research and Markets
Dublin, April 18, 2023 (GLOBE NEWSWIRE) -- The "Effective Defence of EPO (European Patent Office) Patent Applications Training Course" conference has been added to ResearchAndMarkets.com's...
Innovation Scorecard for 3,500+ Companies - Identify the Disruptive Potential of the Companies in Your Investment Portfolio
23 nov. 2022 04h23 HE
|
Research and Markets
Dublin, Nov. 23, 2022 (GLOBE NEWSWIRE) -- The "Company Innovation Scorecard - Ranking 3,500 Innovative Companies on Activity, Impact and Disruptive Potential of their Intellectual Property (IP)...
Citrine Global Corp. (OTCQB: CTGL) Files Provisional Patent Application for Balancing Side Effects
16 nov. 2022 10h10 HE
|
Citrine Global, Corp.
Company also Announces the Introduction of GreenFeelsTM Product Lines Tel Aviv, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Citrine Global Corp. (OTCQB: CTGL) is pleased to announce that the Company’s...
Global Digital Rights Management (DRM) Markets, 2022-2027: Expansion of OTT Platforms & Rise in Corporate Need to Protect Data Present Lucrative Opportunities
30 août 2022 06h58 HE
|
Research and Markets
Dublin, Aug. 30, 2022 (GLOBE NEWSWIRE) -- The "Digital Rights Management Market by Component (Solutions and Services), Application (Audio Content, Images, Video Content, Confidential Documents,...
OWP Pharmaceuticals Announces Patent Application for the First-Ever Oral Liquid Formulation of Atomoxetine Hydrochloride for the Treatment of Attention Deficit Hyperactivity Disorder
22 avr. 2021 08h00 HE
|
OWP Pharmaceuticals
NAPERVILLE, Ill., April 22, 2021 (GLOBE NEWSWIRE) -- OWP Pharmaceuticals, Inc. is a privately held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and...